Central Trust Company’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7
Closed -$281 1655
2026
Q1
$281 Sell
7
-1
-13% -$47 ﹤0.01% 1532
2025
Q4
$360 Buy
+8
New +$370 ﹤0.01% 1475
2023
Q3
Sell
-434
Closed -$20.7K 1381
2023
Q2
$20.7K Sell
434
-207
-32% -$9.98K ﹤0.01% 927
2023
Q1
$31.2K Buy
641
+113
+21% +$5.75K ﹤0.01% 870
2022
Q4
$27.9K Buy
528
+94
+22% +$4.63K ﹤0.01% 878
2022
Q3
$19K Hold
434
﹤0.01% 944
2022
Q2
$22K Buy
+434
New +$21.2K ﹤0.01% 911

Other funds holding QGEN

Central Trust Company's QGEN Position: Q2 2026 in Review

Central Trust Company sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 7 shares — an estimated $281 sold.

Central Trust Company first reported a position in QGEN in Q2 2022 and held it in 7 quarters. The position peaked at $31.2K in Q1 2023. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Central Trust Company reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Central Trust Company sold 7 Qiagen shares in Q2 2026, an estimated $281.
  • Central Trust Company first reported a position in Qiagen in Q2 2022 and held it in 7 quarters.
  • Central Trust Company's Qiagen position peaked at $31.2K in Q1 2023.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.